Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance, beginning of period at Dec. 31, 2019   $ 3 $ 66,503 $ (49,930)
Fair value of private warrants converted to public warrants     0  
Exercise of warrants, net of issuance costs     0  
Stock-based compensation     302  
Stock issued under stock compensation plan     0  
Beneficial conversion feature on convertible notes     93  
Issuance of common stock, net of issuance costs   0 25,007  
Net income (loss) $ (3,481)     (3,481)
Balance, end of period at Jun. 30, 2020 38,497 3 91,905 (53,411)
Balance, beginning of period at Mar. 31, 2020   3 91,750 (51,611)
Fair value of private warrants converted to public warrants     0  
Exercise of warrants, net of issuance costs     0  
Stock-based compensation     155  
Stock issued under stock compensation plan     0  
Beneficial conversion feature on convertible notes     0  
Issuance of common stock, net of issuance costs   0 0  
Net income (loss) (1,800)     (1,800)
Balance, end of period at Jun. 30, 2020 38,497 3 91,905 (53,411)
Balance, beginning of period at Dec. 31, 2020 356,044 8 414,819 (58,783)
Fair value of private warrants converted to public warrants     45,515  
Exercise of warrants, net of issuance costs     138,202  
Stock-based compensation     20,696  
Stock issued under stock compensation plan     2,466  
Beneficial conversion feature on convertible notes     0  
Issuance of common stock, net of issuance costs   1 (890)  
Net income (loss) (55,486)     (55,486)
Balance, end of period at Jun. 30, 2021 506,548 9 620,808 (114,269)
Balance, beginning of period at Mar. 31, 2021   8 435,782 (153,517)
Fair value of private warrants converted to public warrants     31,593  
Exercise of warrants, net of issuance costs     138,202  
Stock-based compensation     14,031  
Stock issued under stock compensation plan     1,275  
Beneficial conversion feature on convertible notes     0  
Issuance of common stock, net of issuance costs   1 (75)  
Net income (loss) 39,248     39,248
Balance, end of period at Jun. 30, 2021 $ 506,548 $ 9 $ 620,808 $ (114,269)